HomeMAIA • NYSEAMERICAN
add
Maia Biotechnology Inc
$1.86
After Hours:(0.54%)-0.0100
$1.85
Closed: Apr 28, 7:27:11 PM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Previous close
$2.00
Day range
$1.80 - $2.00
Year range
$1.40 - $5.99
Market cap
55.03M USD
Avg Volume
163.78K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.00M | -21.53% |
Net income | -3.57M | 42.91% |
Net profit margin | — | — |
Earnings per share | -0.20 | 52.57% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.60M | 34.27% |
Total assets | 10.16M | 34.21% |
Total liabilities | 6.52M | -8.02% |
Total equity | 3.63M | — |
Shares outstanding | 29.59M | — |
Price to book | 14.29 | — |
Return on assets | -129.00% | — |
Return on capital | -476.34% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -3.57M | 42.91% |
Cash from operations | -3.91M | 2.11% |
Cash from investing | — | — |
Cash from financing | 4.85M | -3.58% |
Net change in cash | 910.51K | -12.96% |
Free cash flow | -2.22M | -28.66% |
About
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells. Wikipedia
Founded
2018
Headquarters
Website
Employees
13
